Citi 2Q10 SMID Biotech Earnings Preview: Adjusting AUXL & DNDN Models Ahead of Earnings; Top-Pick is BioMarin (BMRN) Jul 7, 2010 12:42PM
Notable Analyst Rating Changes 10/20: KFT, RIG, BBY, PFE, YGE Upgraded; DE, INTC, MET, POZN Downgraded Oct 20, 2008 09:55AM
Citi Downgrades POZEN Inc (POZN) to Hold Oct 20, 2008 09:01AM
Citi Maintains 'Buy' on POZEN (POZN), Increases Price Target Apr 16, 2008 09:39AM
Citi Maintains 'Buy' Rating on POZEN (POZN) Mar 20, 2008 09:30AM